NASDAQ:HYPD Hyperion DeFi (HYPD) Stock Price, News & Analysis $2.96 -0.44 (-12.94%) Closing price 04:00 PM EasternExtended Trading$3.02 +0.06 (+2.20%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Hyperion DeFi Stock (NASDAQ:HYPD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hyperion DeFi alerts:Sign Up Key Stats Today's Range$2.95▼$3.4850-Day Range$2.52▼$4.6752-Week Range$2.49▼$17.18Volume1.59 million shsAverage Volume730,221 shsMarket Capitalization$44.87 millionP/E RatioN/ADividend YieldN/APrice Target$5.65Consensus RatingHold Company Overview Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York. Read More Hyperion DeFi Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreHYPD MarketRank™: Hyperion DeFi scored higher than 73% of companies evaluated by MarketBeat, and ranked 110th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingHyperion DeFi has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 2 sell ratings.Upside PotentialHyperion DeFi has a consensus price target of $5.65, representing about 90.9% upside from its current price of $2.96.Amount of Analyst CoverageHyperion DeFi has only been the subject of 4 research reports in the past 90 days.Read more about Hyperion DeFi's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-32.75% Earnings GrowthEarnings for Hyperion DeFi are expected to decrease by -32.75% in the coming year, from $1.71 to $1.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperion DeFi is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperion DeFi is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperion DeFi has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.27% of the float of Hyperion DeFi has been sold short.Short Interest Ratio / Days to CoverHyperion DeFi has a short interest ratio ("days to cover") of 1.98, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hyperion DeFi has recently increased by 50.74%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHyperion DeFi does not currently pay a dividend.Dividend GrowthHyperion DeFi does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.44 News SentimentHyperion DeFi has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Hyperion DeFi this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for HYPD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.4 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $29,560.00 in company stock, which represents 0.0659% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Hyperion DeFi insiders have bought more of their company's stock than they have sold. Specifically, they have bought $29,560.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders7.50% of the stock of Hyperion DeFi is held by insiders.Percentage Held by Institutions25.84% of the stock of Hyperion DeFi is held by institutions.Read more about Hyperion DeFi's insider trading history. Receive HYPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperion DeFi and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HYPD Stock News HeadlinesHyperion Gains on Blockdaemon HookupJune 23 at 2:29 PM | baystreet.caHyperion DeFi Taps Blockdaemon to Expand Hyperliquid Staking InfrastructureJune 23 at 2:29 PM | finance.yahoo.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.June 25 at 1:00 AM | Weiss Ratings (Ad)Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking InfrastructureJune 22 at 8:00 AM | globenewswire.comAnalysts Conflicted on These Healthcare Names: Aveanna Healthcare Holdings (AVAH), Kura Oncology (KURA) and Hyperion DeFi (HYPD)June 12, 2026 | theglobeandmail.comHyperion DeFi Reiterates Guidance on Sunset of USDH and Felix MarketsJune 8, 2026 | markets.businessinsider.comHyperion DeFi, Inc. Maintains 2026 Financial Guidance Despite Partnership Changes with Native Markets and Felix MarketsJune 8, 2026 | quiverquant.comQHyunsu Jung Acquires 7,000 Shares of Hyperion DeFi (NASDAQ:HYPD) StockJune 3, 2026 | insidertrades.comSee More Headlines HYPD Stock Analysis - Frequently Asked Questions How have HYPD shares performed this year? Hyperion DeFi's stock was trading at $3.56 at the start of the year. Since then, HYPD stock has decreased by 16.9% and is now trading at $2.96. How were Hyperion DeFi's earnings last quarter? Hyperion DeFi, Inc. (NASDAQ:HYPD) released its quarterly earnings data on Friday, November, 14th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $0.36 million for the quarter. When did Hyperion DeFi's stock split? Hyperion DeFi shares reverse split on the morning of Monday, February 3rd 2025.The 1-80 reverse split was announced on Tuesday, January 28th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 31st 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. Who are Hyperion DeFi's major shareholders? Top institutional investors of Hyperion DeFi include Redwood Wealth Management Group LLC (1.61%) and Renaissance Technologies LLC (0.95%). Insiders that own company stock include Hyunsu Jung, David R Knox, Stuart M Grant, Ellen R Strahlman, Michael S Geltzeiler and Michael M Rowe. View institutional ownership trends. How do I buy shares of Hyperion DeFi? Shares of HYPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/14/2025Today6/25/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (7m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 HYPD's financial health is in the Yellow zone, according to TradeSmith. HYPD has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:HYPD Previous SymbolNASDAQ:EYEN CIK1682639 Webwww.eyenovia.com Phone(917) 289-1117FaxN/AEmployees40Year Founded2014Price Target and Rating Average Price Target for Hyperion DeFi$5.65 High Price Target$7.30 Low Price Target$4.00 Potential Upside/Downside+90.9%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($9.95) Trailing P/E RatioN/A Forward P/E Ratio1.73 P/E GrowthN/ANet Income-$45.31 million Net MarginsN/A Pretax Margin-3,162.90% Return on Equity-91.59% Return on Assets-73.08% Debt Debt-to-Equity Ratio0.12 Current Ratio1.97 Quick Ratio1.97 Sales & Book Value Annual Sales$810 thousand Price / Sales55.40 Cash FlowN/A Price / Cash FlowN/A Book Value$4.73 per share Price / Book0.63Miscellaneous Outstanding Shares15,160,000Free Float14,021,000Market Cap$44.87 million OptionableNo Data Beta2.47 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:HYPD) was last updated on 6/25/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperion DeFi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperion DeFi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HYPD Stock Alerts